This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Talecris Biotherapeutics, Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations of Jonathan D Kent
Introduction
Jonathan D Kent is an accomplished inventor based in Holly Springs, NC (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of processes related to plasmin compositions. His work has implications for thrombolytic therapy, showcasing his commitment to advancing medical science.
Latest Patents
Jonathan D Kent holds a patent for a "Process for the production of a reversibly inactive acidified plasmin composition." This patent discloses a method for producing a reversibly inactive acidified plasmin by activating plasminogen. Additionally, it outlines a process for producing purified plasminogen. The produced plasmin is isolated and stored with a low pH-buffering capacity agent, ensuring a substantially stable formulation. The purified plasminogen is typically derived from a fraction obtained during the separation of immunoglobulin from the Fraction II+III chromatographic process and is eluted at a low pH. The reversibly inactive acidified plasmin may be utilized in administering thrombolytic therapy.
Career Highlights
Jonathan D Kent is associated with Talecris Biotherapeutics, Inc., where he applies his expertise in biotherapeutics. His innovative work has contributed to the company's mission of developing life-saving therapies.
Collaborations
Some of his notable coworkers include Rita T Bradley and Jonathan S Strauss, who collaborate with him in advancing the company's research and development efforts.
Conclusion
Jonathan D Kent's contributions to the field of biotherapeutics through his innovative patent and work at Talecris Biotherapeutics, Inc. highlight his role as a significant inventor in the medical field. His efforts continue to pave the way for advancements in thrombolytic therapy.